ELISA
LUÑO FERNANDEZ
Investigador/a
Hospital Universitario Araba
Vitoria, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Araba (21)
2017
-
Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes
Cancer Letters, Vol. 409, pp. 42-48
-
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
Leukemia Research, Vol. 63, pp. 85-89
-
Excess mortality in the myelodysplastic syndromes
American Journal of Hematology, Vol. 92, Núm. 2, pp. 149-154
-
Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance
American Journal of Hematology
-
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
Oncotarget, Vol. 8, Núm. 33, pp. 54297-54303
2016
-
Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes
Journal of Clinical Oncology, Vol. 34, Núm. 27, pp. 3284-3292
-
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: A rationale for its inclusion into future classifications of myelodysplastic syndromes
Modern Pathology, Vol. 29, Núm. 12, pp. 1541-1551
-
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
Oncotarget, Vol. 7, Núm. 49, pp. 80916-80924
-
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes
Genes Chromosomes and Cancer, Vol. 55, Núm. 4, pp. 322-327
2015
-
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry
Leukemia, Vol. 29, Núm. 9, pp. 1875-1881
-
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: A population-based study
The Lancet Haematology, Vol. 2, Núm. 6, pp. e260-e266
2014
-
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: Different genetic mechanisms but equivalent poorer clinical outcome
Genes Chromosomes and Cancer, Vol. 53, Núm. 9, pp. 788-797
-
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis
Leukemia Research, Vol. 38, Núm. 3, pp. 304-309
2013
-
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: Analysis of 627 patients with isolated 13q deletion
British Journal of Haematology, Vol. 163, Núm. 1, pp. 47-54
-
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome
Leukemia Research, Vol. 37, Núm. 7, pp. 769-776
-
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome
Journal of Clinical Oncology, Vol. 31, Núm. 7, pp. 916-922
-
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype
Genes Chromosomes and Cancer, Vol. 52, Núm. 8, pp. 753-763
2012
-
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
Leukemia Research, Vol. 36, Núm. 3, pp. 287-292
2011
-
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Haematologica, Vol. 96, Núm. 3, pp. 375-383
-
Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome
Cancer, Vol. 117, Núm. 24, pp. 5529-5537